Test Bank for Understanding Pharmacology Essentials for Medication Safety,
3rd Edition by M. Linda Workman & LaCharity
O
O O O O O O
,ChapterO01:ODrugORegulation,OActions,OandOResponses
WorkmanO&OLaCharity:OUnderstandingOPharmacology:OEssentialsOforOMedicationOSafety,O3rdOEdition
MULTIPLEOCHOICEOBASICO CONC
EPTS
1. WhichOhealthOcareOprofessionalOhasOtheOmajorOresponsibilityOforOdispensingOprescribed
O drugsOunderOtheOdirectionOofOaOpharmacist?
a. Physician
b NurseOpractitioner
.
c. LicensedOnurse
d PharmacyOtechnician
.
ANS:OO D
TheOphysicianOandOnurseOpractitionerOhaveOtheOmajorOresponsibilityOforOprescribingOdrugs,OnotO dispe
nsingOthem.OTheOlicensedOnurseOhasOtheOprimaryOresponsibilityOforOadministeringOdrugs,O althoughOu
nderOsomeOcircumstancesOaOlicensedOnurseOmayOdispenseOprescribedOdrugsObutOthisOisOnotO hisOorOherO
majorOresponsibilityOinOdrugOtherapy.OTheOpharmacyOtechnicianOhasOtheOmajorO responsibilityOofOdisp
ensingOprescribedOdrugsOunderOtheOdirectionOofOaOlicensedOpharmacist.
DIF: CognitiveOLevel:ORemembering REF: p.O3
2. WhichOtermOdescribesOtheOeffectOofOaOdrugOthatOimprovesObodyOfunction?
a. SideOeffect
b IntendedOaction
.
c. AdverseOreaction
d IdiosyncraticOresponse
.
ANS:OO B
TheOpurposeOofOdrugOtherapyOisOtoOtakeOaOdrugOtoOprevent,Oreduce,OorOcorrectOaOhealthOproblem.OThis
responseOisOanyOdrug’sOintendedOactionOalsoOknownOasOaOtherapeuticOresponse.
DIF: CognitiveOLevel:ORemembering REF: p.O3
3. WhichOtypeOofOdrugOnameOisO“owned”ObyOtheOcompanyOthatOmanufacturesOit?
a. GenericOname
b ChemicalOname
,.
c. CategoryOname
d TradeOname
.
ANS:OO D
TheOchemicalOnameOisOaOdrug’sOexactOchemicalOcomposition.OTheOgenericOnameOisOtheOnameOassignedOt
oO theOdrugObyOtheOU.S.OAdoptedONamesOCouncilOandOisOnotOownedObyOanyone.OTheOcategoryOnameOrefe
rsO toOtheOtypeOofOdrugO(whatOitOdoesOorOwhatOitOisOusedOfor)OandOisOnotOanOactualOdrugOname.OTheOtrade
O nameO(brandOname)OisOtheOnameOprovidedOandOownedObyOaOspecificOdrug’sO manufacturer.
DIF: CognitiveOLevel:ORemembering REF: p.O4
4. WhichOdrugOorOdrugOclassOisOaO“highOalert”Odrug
a. Penicillin
?
b Insulin
.
c. NSAIDs
d Calcium
.
ANS:OO B
AOhighOalertOdrugOisOoneOinOwhichOharmOisOlikelyOtoOresultOifOgivenOatOtheOwrongOdose,OtoOtheOwrongO p
atient,OorOnotOgivenOtoOtheOcorrectOpatient.ODrugsOclassifiedOasOhighOalertOdrugsOincludeOpotassium,O na
rcoticsO(opioids),Oinsulin,OcancerOchemotherapyOdrugs,OandOheparinO(orOanyOdrugOthatOstronglyO affect
sObloodOclotting).OPenicillin,ONSAIDs,OandOcalciumOareOnotOconsideredOhighOalertOdrugs.
DIF: CognitiveOLevel:ORemembering REF: p.O4
5. WhatOisOtheOtermOforOaOdrugOthatOhasOtheOsameOactionOasOaOnaturallyOoccurringObod
yO hormoneOorOenzyme?
a. Agonist
b BlockingOagent
.
c. Chemical
d Duplicator
.
ANS:OO A
AOdrugOagonistOisOanOextrinsicOdrugOthatOactivatesOtheOreceptorOsitesOofOaOcellOandOmimicsOtheOactionsOofO
naturallyOoccurringObodyOsubstancesO(intrinsicOdrugs).OAOblockingOagentOisOaOdrug
, antagonist.OAOchemicalOwouldOnotOnecessarilyObeOaOdrugOatOall.OAOduplicatorOisOnotOaOpharmacologicOter
m.O DIF: CognitiveOLevel:ORemembering REF: pp.O6-7
6. WhichOtermOdescribesOhowOtheObodyOaffectsOdrugOactivity?
a. DrugOpotency
b Pharmacodynamics
.
c. TherapeuticOeffect
d Pharmacokinetics
.
ANS:OO D
TheOtermOpharmacokineticsOrefersOtoOdrugOmetabolismOandOhowOtheObodyOchangesOaOdrug.O Pharmac
odynamicsOrefersOtoOhowOaOdrugOworksOtoOchangeObodyOfunction.ODrugOpotencyOrefersOtoOhowO strongl
yOorOtoOwhatOdegreeOaOdrugOexertsOitsOeffects.OTheOtherapeuticOeffectOisOcloserOtoO pharmacodynamics,O
meaningOhowOaOdrugOworksOtoOchangeObodyOfunction.
DIF: CognitiveOLevel:ORemembering REF: p.O10
7. InOtheOUnitedOStates,OwhichOgroupOisOresponsibleOforOenforcingOestablishedOstandardsOfo
rO drugOmanufacturing?
a. U.S.OPharmacopeia
b NationalOInstitutesOofOHealth
.
c. FoodOandODrugOAdministration
d AssociationOofOPharmaceuticalOManufacturers
.
ANS:OO C
TheOstandardsOforOdrugOmanufactureOareOestablishedObyOtheOU.S.OPharmacopeia.OTheseO standardsOare
O enforcedO byO theO FoodO andO DrugO Administration.O NeitherO theO NationalO InstitutesO ofO HealthO norO t
heO AssociationOofOPharmaceuticalOManufacturersOhasOanyOauthorityOtoOenforceOdrugOstandards.
DIF:OOOO CognitiveOLevel:ORememberingOOOOOOOOO REF:OOO p.O5
8. WhichOfactorOisOaOmajorOdisadvantageOofOtheOtransdermalOdrugOdeliveryOroute?
a. OnlyOaOprescriberOcanOadministerOdrugsObyOtheOtransdermalOroute.
b TransdermalOdrugsOmustObeOsterileOratherOthanOclean.
.
c. FirstOpassOdrugOlossObyOthisOrouteOisOtheOmostOextensive.
d DrugOabsorptionOisOdependentOonOadequateOcirculation.
3rd Edition by M. Linda Workman & LaCharity
O
O O O O O O
,ChapterO01:ODrugORegulation,OActions,OandOResponses
WorkmanO&OLaCharity:OUnderstandingOPharmacology:OEssentialsOforOMedicationOSafety,O3rdOEdition
MULTIPLEOCHOICEOBASICO CONC
EPTS
1. WhichOhealthOcareOprofessionalOhasOtheOmajorOresponsibilityOforOdispensingOprescribed
O drugsOunderOtheOdirectionOofOaOpharmacist?
a. Physician
b NurseOpractitioner
.
c. LicensedOnurse
d PharmacyOtechnician
.
ANS:OO D
TheOphysicianOandOnurseOpractitionerOhaveOtheOmajorOresponsibilityOforOprescribingOdrugs,OnotO dispe
nsingOthem.OTheOlicensedOnurseOhasOtheOprimaryOresponsibilityOforOadministeringOdrugs,O althoughOu
nderOsomeOcircumstancesOaOlicensedOnurseOmayOdispenseOprescribedOdrugsObutOthisOisOnotO hisOorOherO
majorOresponsibilityOinOdrugOtherapy.OTheOpharmacyOtechnicianOhasOtheOmajorO responsibilityOofOdisp
ensingOprescribedOdrugsOunderOtheOdirectionOofOaOlicensedOpharmacist.
DIF: CognitiveOLevel:ORemembering REF: p.O3
2. WhichOtermOdescribesOtheOeffectOofOaOdrugOthatOimprovesObodyOfunction?
a. SideOeffect
b IntendedOaction
.
c. AdverseOreaction
d IdiosyncraticOresponse
.
ANS:OO B
TheOpurposeOofOdrugOtherapyOisOtoOtakeOaOdrugOtoOprevent,Oreduce,OorOcorrectOaOhealthOproblem.OThis
responseOisOanyOdrug’sOintendedOactionOalsoOknownOasOaOtherapeuticOresponse.
DIF: CognitiveOLevel:ORemembering REF: p.O3
3. WhichOtypeOofOdrugOnameOisO“owned”ObyOtheOcompanyOthatOmanufacturesOit?
a. GenericOname
b ChemicalOname
,.
c. CategoryOname
d TradeOname
.
ANS:OO D
TheOchemicalOnameOisOaOdrug’sOexactOchemicalOcomposition.OTheOgenericOnameOisOtheOnameOassignedOt
oO theOdrugObyOtheOU.S.OAdoptedONamesOCouncilOandOisOnotOownedObyOanyone.OTheOcategoryOnameOrefe
rsO toOtheOtypeOofOdrugO(whatOitOdoesOorOwhatOitOisOusedOfor)OandOisOnotOanOactualOdrugOname.OTheOtrade
O nameO(brandOname)OisOtheOnameOprovidedOandOownedObyOaOspecificOdrug’sO manufacturer.
DIF: CognitiveOLevel:ORemembering REF: p.O4
4. WhichOdrugOorOdrugOclassOisOaO“highOalert”Odrug
a. Penicillin
?
b Insulin
.
c. NSAIDs
d Calcium
.
ANS:OO B
AOhighOalertOdrugOisOoneOinOwhichOharmOisOlikelyOtoOresultOifOgivenOatOtheOwrongOdose,OtoOtheOwrongO p
atient,OorOnotOgivenOtoOtheOcorrectOpatient.ODrugsOclassifiedOasOhighOalertOdrugsOincludeOpotassium,O na
rcoticsO(opioids),Oinsulin,OcancerOchemotherapyOdrugs,OandOheparinO(orOanyOdrugOthatOstronglyO affect
sObloodOclotting).OPenicillin,ONSAIDs,OandOcalciumOareOnotOconsideredOhighOalertOdrugs.
DIF: CognitiveOLevel:ORemembering REF: p.O4
5. WhatOisOtheOtermOforOaOdrugOthatOhasOtheOsameOactionOasOaOnaturallyOoccurringObod
yO hormoneOorOenzyme?
a. Agonist
b BlockingOagent
.
c. Chemical
d Duplicator
.
ANS:OO A
AOdrugOagonistOisOanOextrinsicOdrugOthatOactivatesOtheOreceptorOsitesOofOaOcellOandOmimicsOtheOactionsOofO
naturallyOoccurringObodyOsubstancesO(intrinsicOdrugs).OAOblockingOagentOisOaOdrug
, antagonist.OAOchemicalOwouldOnotOnecessarilyObeOaOdrugOatOall.OAOduplicatorOisOnotOaOpharmacologicOter
m.O DIF: CognitiveOLevel:ORemembering REF: pp.O6-7
6. WhichOtermOdescribesOhowOtheObodyOaffectsOdrugOactivity?
a. DrugOpotency
b Pharmacodynamics
.
c. TherapeuticOeffect
d Pharmacokinetics
.
ANS:OO D
TheOtermOpharmacokineticsOrefersOtoOdrugOmetabolismOandOhowOtheObodyOchangesOaOdrug.O Pharmac
odynamicsOrefersOtoOhowOaOdrugOworksOtoOchangeObodyOfunction.ODrugOpotencyOrefersOtoOhowO strongl
yOorOtoOwhatOdegreeOaOdrugOexertsOitsOeffects.OTheOtherapeuticOeffectOisOcloserOtoO pharmacodynamics,O
meaningOhowOaOdrugOworksOtoOchangeObodyOfunction.
DIF: CognitiveOLevel:ORemembering REF: p.O10
7. InOtheOUnitedOStates,OwhichOgroupOisOresponsibleOforOenforcingOestablishedOstandardsOfo
rO drugOmanufacturing?
a. U.S.OPharmacopeia
b NationalOInstitutesOofOHealth
.
c. FoodOandODrugOAdministration
d AssociationOofOPharmaceuticalOManufacturers
.
ANS:OO C
TheOstandardsOforOdrugOmanufactureOareOestablishedObyOtheOU.S.OPharmacopeia.OTheseO standardsOare
O enforcedO byO theO FoodO andO DrugO Administration.O NeitherO theO NationalO InstitutesO ofO HealthO norO t
heO AssociationOofOPharmaceuticalOManufacturersOhasOanyOauthorityOtoOenforceOdrugOstandards.
DIF:OOOO CognitiveOLevel:ORememberingOOOOOOOOO REF:OOO p.O5
8. WhichOfactorOisOaOmajorOdisadvantageOofOtheOtransdermalOdrugOdeliveryOroute?
a. OnlyOaOprescriberOcanOadministerOdrugsObyOtheOtransdermalOroute.
b TransdermalOdrugsOmustObeOsterileOratherOthanOclean.
.
c. FirstOpassOdrugOlossObyOthisOrouteOisOtheOmostOextensive.
d DrugOabsorptionOisOdependentOonOadequateOcirculation.